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Everywhere health policy makers experience a grow- 
ing gap between what is medically possible and what 
is economically feasible. So it becomes ever more 
necessary to deploy the resources available for health 
care as efficiently as possible. In the last three decades 
we have seen increasing research activity in the area 
of economic appraisal of health care interventions 
and programmes. Recently, an exponential rise in the 
number of published studies was observed [l, 21. 
There is relatively little evidence, however, of the use 
of such studies in health policy and of their actual 
impact. At a European Community workshop in 
Crete, October 1992, which was held under the title 
“From results to action: the role of economic ap- 
praisal in developing policy for health technology”, 
an attempt was made to clarify the role of economic 
appraisal in health policy and to understand the 
mechanisms which contribute to the appropriate use 
of information on cost-effectiveness in health care 
decision-making. 
This special issue contains a selection of the papers 
presented at this workshop. The organizer of the 
workshop, Drummond, introduces the issue in the 
first paper, and describes a wide range of policy 
options to rationalize the diffusion and use of health 
technologies, to some of which economic appraisal is 
applied or is potentially applicable. Furthermore, he 
provides a number of suggestions on how to make 
economic appraisal more relevant to decision- 
making. The paper by Davies et al. reports on a 
survey of economic evaluations in EC countries to 
identify the impact of the results on decision- and 
policy-making in health care. The results of the 
survey suggest that there is scope for improving the 
impact of economic appraisal and that the method 
of dissemination, the source of funding and the 
initial objectives of a given study may be important 
determinants of its use. 
After these two introductory papers the specific 
situation in a number of countries is discussed, taking 
a specific perspective in each case. Rutten and van der 
Linden discuss the role of economic appraisal in 
insurance based health care systems, using the case of 
the Netherlands as an example. The role of the 
organization governing the public insurance scheme 
is highlighted, as this agency has assessed several 
methods of initiating research in this field and is 
committed to use economic appraisal results for 
policy development. This situation may change when 
the system becomes more decentralized, forcing new 
actors to make themselves acquainted with and use 
economic evaluation techniques. Henshall and 
Drummond consider the actual and potential use of 
economic appraisal in the management of the Na- 
tional Health Service in the United Kingdom, and 
they suggest that the recent reforms may even in- 
crease the opportunities and demand for economic 
evaluation. Furthermore, they discuss a number of 
practical problems, such as the generation of reliable 
and relevant economic data, the targeting of these 
data to the appropriate decision-makers and the 
supply of resources and expertise. These problems are 
common to most countries. Moatti et al. throw more 
light on the debate concerning ‘researcher driven’ vs 
‘policy driven’ economic research, suggesting the 
need of instituting ‘intermediate’ expert structures 
and the requirement for researchers specifically to 
take into account decision-makers’ objectives and 
constraints. In this respect they point to new insti- 
tutions in France intended to help bridge the gap 
between research and policy. 
France describes a health system in turmoil in 
Italy, where he observes only minimal impact of 
economic appraisal and where there is confusion 
about the division of responsibilities between central 
and regional governments. The latter is identified as 
a key problem to strengthening the role of economic 
appraisal. The regional perspective is highlighted by 
Granados and BorrBs, who describe the position of a 
Catalan agency for technology assessment as a part 
of the regional department of health. This is one of 
the rare examples where research in this area is 
carried out by a department within a governmental 
agency, and the authors discuss the advantages and 
disadvantages of such position. Alban describes the 
various ways in which economic appraisal is support- 
ing health policy in a decentralized system like in 
Denmark. She stresses the necessity to educate both 
managers and politicians in the concept of efficiency 
and the appropriate use of the results of economic 
appraisal. Finally, Selby Smith et al. use eight 
examples to illustrate the policy context for economic 
appraisal in Australia and its actual impact on health 
policy, medical practice and health status. These 
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examples clearly illustrate the need for establishing 
strong links between the various players in the re- 
search and policy area. 
Each of the last three papers in this special issue 
considers a specific topic in relation to economic 
appraisal. The first, by Banta and Vondeling, deals 
with the delicate problem of the timing of an econ- 
omic appraisal. They illustrate this problem using the 
case of lasers, which are diffusing relatively rapidly in 
health care, while few of their applications have been 
well evaluated. They propose an integrated strategy 
of monitoring and regulating diffusion and simul- 
taneously initiating a programme of economic ap- 
praisal. Rovira makes a plea for standardization of 
the methodology of economic appraisal to ensure 
comparability and to foster transferability of the 
results of studies in this field. Finally, Szczepura and 
Kankaanpaa present the results of a survey on the 
interest in assessment of health care technologies 
among European organizations and their needs for 
training both policy-makers and researchers in this 
field. 
What can be concluded from the papers as a 
group? First, only in a few cases has an official role 
for economic appraisal in health policy been formu- 
lated, but in more cases one can observe an actual 
impact of such studies. Secondly, close links between 
researchers and policy-makers help the latter to inter- 
pret appropriately the results of economic appraisal 
and to further an adequate use in policy-making. 
Researchers on the other hand should understand the 
policy context of the research and the options and 
restrictions faced by policy-makers. A continuous 
dialogue between analysts and decision-makers is 
useful. Thirdly, there seems to be a wide range of 
policy instruments available for which economic ap- 
praisal results can be used, and the choice of the best 
policy option depends on the type of technology, on 
its position in the diffusion cycle and on the general 
health policy context. Fourthly, the analysis needs to 
be relevant to local circumstances. Given the need for 
analysis to be well focused it is not easy to use results 
from studies performed elsewhere. Methods are be- 
coming available to help in the transfer of economic 
appraisal results, although this is not straightforward. 
And finally, the information produced by economic 
appraisal may improve the performance of the mar- 
ket for health care if the objective of such a market 
is the supply of cost-effective technologies and their 
efficient use. The supply of economic data is a 
necessary condition for efficiency in health care. 
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